Press Releases
PANTHERx® Rare Named to USA Today’s List of Top Workplaces for 2025
March 20, 2025
PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty pharmacies, announced today that it has been recognized as one of the Top Places to Work by USA Today. This prestigious recognition highlights...
Read More
PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen)
December 23, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Ionis Pharmaceuticals, Inc. for the distribution of TRYNGOLZA™ (olezarsen), the first...
Read More
Neurocrine Biosciences, Inc. Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont)
December 20, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Neurocrine Biosciences, Inc. for the distribution of CRENESSITY™ (crinecerfont), an...
Read More
Ascendis Pharma Selects PANTHERx® Rare for the Distribution of YORVIPATH® (palopegteriparatide)
December 6, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with Ascendis Pharma for the distribution of YORVIPATH®, a FDA approved parathyroid hormone...
Read More
BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby™ (acoramidis)
November 25, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by BridgeBiofor the distribution of Attruby™ (acoramidis), a high-affinity transthyretin...
Read More
PANTHERx® Rare Selected by Calliditas Therapeutics as Specialty Pharmacy for TARPEYO®
September 3, 2024
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Calliditas Therapeutics for the exclusive distribution of TARPEYO® (budesonide) delayed...
Read More
No posts found